Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 34.0 | 63 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 60.0 | 50 | |
RA2159 | PI103 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 40.0 | 63 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 51.0 | 64 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 36.5 | 90 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 38.0 | 55 | |
RA2159 | Lestaurtinib | 0.3 | uM | 2 | IFN-a2 | 18.5 | 64 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 114.0 | 43 | ||||
N2586 | EO1428 | 1.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 206.5 | 54 | |
N2586 | PI103 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 118.0 | 56 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 151.5 | 52 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 81.0 | 63 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-a2 | 105.0 | 59 | |
N2586 | Lestaurtinib | 0.3 | uM | 2 | IFN-a2 | 37.0 | 69 | ||||
RA2159 | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 20.5 | 76 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 18.0 | 60 | |
RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 25.0 | 84 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 22.5 | 44 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 20.5 | 58 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 17.5 | 30 | |
RA2159 | Ruxolitinib | 0.3 | uM | 2 | IFN-a2 | 21.5 | 50 | ||||
N2586 | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 48.0 | 66 | ||||
N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 43.0 | 75 | |
N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 45.0 | 57 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | IFN-a2 | 49.0 | 67 |